Single‐cell RNA sequencing reveals that NRF2 regulates vascular smooth muscle cell phenotypic switching in abdominal aortic aneurysm

Abstract Abdominal aortic aneurysm (AAA) is a life‐threatening disease characterized by extensive membrane destruction in the vascular wall that is closely associated with vascular smooth muscle cell (VSMC) phenotypic switching. A thorough understanding of the changes in regulatory factors during VSMC phenotypic switching is essential for managing AAA therapy. In this study, we revealed the impact of NRF2 on the modulation of VSMC phenotype and the development of AAA based on single‐cell RNA sequencing analysis. By utilizing a murine model of VSMC‐specific knockout of nuclear factor E2‐related factor 2 (NRF2), we observed that the absence of NRF2 in VSMCs exacerbated AAA formation in an angiotensin II‐induced AAA model. The downregulation of NRF2 promoted VSMC phenotypic switching, leading to an enhanced inflammatory response. Through genome‐wide transcriptome analysis and loss‐ or gain‐of‐function experiments, we discovered that NRF2 upregulated the expression of VSMC contractile phenotype‐specific genes by facilitating microRNA‐145 (miR‐145) expression. Our data identified NRF2 as a novel regulator involved in maintaining the VSMC contractile phenotype while also influencing AAA formation through an miR‐145‐dependent regulatory mechanism.